The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes
出版年份 2020 全文链接
标题
The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes
作者
关键词
-
出版物
CLINICAL INFECTIOUS DISEASES
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-03-10
DOI
10.1093/cid/ciaa259
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of HIV/SIV infection and viral proteins on adipose tissue fibrosis and adipogenesis
- (2019) Jennifer Gorwood et al. AIDS
- Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
- (2019) Paola Bagella et al. Infection and Drug Resistance
- Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment
- (2019) Claire Lagathu et al. Expert Opinion On Drug Safety
- Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study
- (2019) Christine Katlama et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
- (2019) Willem D.F. Venter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1
- (2019) NEW ENGLAND JOURNAL OF MEDICINE
- Adipocytes impair efficacy of antiretroviral therapy
- (2018) Jacob Couturier et al. ANTIVIRAL RESEARCH
- Oxidative Stress Inhibits Healthy Adipose Expansion Through Suppression of SREBF1-Mediated Lipogenic Pathway
- (2018) Yosuke Okuno et al. DIABETES
- Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy
- (2018) Obiageli Offor et al. PLoS One
- A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017
- (2018) Mario Gomez et al. INFECTION
- Relationships between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons with HIV after 96 weeks of Antiretroviral Therapy
- (2018) Todd Hulgan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot
- (2018) Paula Debroy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Brief Report
- (2017) Jamison Norwood et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dolutegravir-induced hyperglycaemia in a patient living with HIV
- (2017) Milena McLaughlin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The FAT Score, a Fibrosis Score of Adipose Tissue: Predicting Weight-Loss Outcome After Gastric Bypass
- (2017) Pierre Bel Lassen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short Communication: Comparative Evaluation of Coformulated Injectable Combination Antiretroviral Therapy Regimens in Simian Immunodeficiency Virus-Infected Rhesus Macaques
- (2016) Gregory Q. Del Prete et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines
- (2016) Ricardo Moure et al. ANTIVIRAL RESEARCH
- Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s
- (2016) Grace A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals
- (2016) Melissa Herrin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Higher Time-Updated Body Mass Index
- (2016) John R. Koethe et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
- (2016) Sahera Dirajlal-Fargo et al. Open Forum Infectious Diseases
- Effects of raltegravir combined with tenofovir/emtricitabine on body shape, bone density, and lipids in African-Americans initiating HIV therapy
- (2015) Laura Young et al. HIV CLINICAL TRIALS
- Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study
- (2015) AC Achhra et al. HIV MEDICINE
- Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection
- (2015) Abderaouf Damouche et al. PLoS Pathogens
- Differential penetration of raltegravir throughout gastrointestinal tissue
- (2013) Kristine B. Patterson et al. AIDS
- Fibrosis and Adipose Tissue Dysfunction
- (2013) Kai Sun et al. Cell Metabolism
- Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
- (2013) Morihiro Matsuda et al. Obesity Research & Clinical Practice
- LMNA Mutations Induce a Non-Inflammatory Fibrosis and a Brown Fat-Like Dystrophy of Enlarged Cervical Adipose Tissue
- (2011) Véronique Béréziat et al. AMERICAN JOURNAL OF PATHOLOGY
- Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes
- (2011) Emilie Capel et al. ANTIVIRAL THERAPY
- Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes
- (2011) Patricia Perez-Matute et al. CURRENT HIV RESEARCH
- Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir
- (2010) Rumi Minami et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- HIV-associated lipodystrophy: from fat injury to premature aging
- (2010) Martine Caron-Debarle et al. TRENDS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search